Filana Therapeutics, Inc. (FLNA)
CIK 1069530 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Filana Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jul 29, 2026 | 10-Q | 0001437749-26-024752 |
| Jul 29, 2026 | 8-K | 0001171843-26-004982 |
| Jun 15, 2026 | 8-K | 0001437749-26-020562 |
| May 7, 2026 | 8-K | 0001171843-26-003119 |
| May 7, 2026 | 10-Q | 0001437749-26-015664 |
| Apr 28, 2026 | DEF 14A | 0001437749-26-013654 |
| Apr 28, 2026 | 8-K | 0001437749-26-013638 |
| Apr 28, 2026 | ARS | 0001437749-26-013656 |
| Mar 12, 2026 | 10-K | 0001437749-26-007962 |
| Mar 12, 2026 | 8-K | 0001171843-26-001506 |
| Mar 10, 2026 | 8-K | 0001437749-26-007422 |
| Feb 19, 2026 | 8-K | 0001171843-26-000922 |
| Dec 23, 2025 | 8-K | 0001437749-25-038605 |
| Dec 22, 2025 | 8-K/A | 0001437749-25-038544 |
| Dec 18, 2025 | 8-K | 0001437749-25-038313 |
| Dec 17, 2025 | 8-K | 0001437749-25-038157 |
| Dec 5, 2025 | EFFECT | 9999999995-25-003554 |
| Dec 5, 2025 | 424B2 | 0001493152-25-026408 |
| Dec 3, 2025 | 8-K | 0001437749-25-036710 |
| Nov 25, 2025 | 4 | 0001437749-25-036321 |
| Nov 24, 2025 | 4 | 0001437749-25-036125 |
| Nov 20, 2025 | 4 | 0001437749-25-035882 |
| Nov 13, 2025 | S-3 | 0001493152-25-022066 |
| Oct 24, 2025 | 8-K | 0001437749-25-031674 |
| Oct 22, 2025 | 3 | 0001437749-25-031538 |